Social and demographic predictors of willingness to participate in an exception from informed consent trial

Abstract Background Community consultation and public disclosure are key components of exception from informed consent (EFIC) trials, and mandated by the US Department of Health and Human Services (DHHS) and the Food and Drug Administration (FDA). However, it is not known how demographic characteris...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Shannon W. Stephens, Christy Carroll-Ledbetter, Sarah Duckert, Margaret Nelson, Joel Rodgers, Russell L. Griffin, Amy Suen, Jeremy Casey, Steven R. Sloan, Adam McClintock, Sara F. Goldkind, Luke Gelinas, Amanda E. Higley, Bellal Joseph, John B. Holcomb, Jan O. Jansen, TAP Study Group
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	BMC 2026-02-01
סדרה:	BMC Medical Ethics
נושאים:	Community consultation Public disclosure Clinical trial Exception from informed consent
גישה מקוונת:	https://doi.org/10.1186/s12910-026-01394-7
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!